The Role of Hair Restoration Surgery in Primary Cicatricial Alopecia

    January 2016 in “ Skin appendage disorders ”
    Maurice J. Dahdah, Matilde Iorizzo
    Image of study
    TLDR Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.
    The 2015 review "The Role of Hair Restoration Surgery in Primary Cicatricial Alopecia" discussed the potential of surgical treatments for primary scarring alopecias, which accounted for up to 7.3% of hair loss cases in specialty clinics. The authors noted that pharmacological treatments could only prevent further hair loss, not induce regrowth. Two main surgical techniques, surgical excision and hair transplant, were discussed, with the choice depending on various factors such as type of alopecia, location of hair loss, and patient's wound healing characteristics. The authors emphasized the importance of early pharmacological treatment, patient remission before hair transplant, and post-surgery monitoring. They also highlighted potential complications and the risk of disease reactivation post-surgery. The effectiveness of starting pharmacological treatment immediately after surgery was yet to be determined. The document did not provide the number of patients involved in the study.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 288 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    6 / 6 results